Penn Medicine Provider
Gynecologic Oncology
Noah Adam Goldman, MD, MBA
4.9
(173)
Accepting new patients
Sees patients age 18 and up
Princeton Medicine Physicians - Gynecologic Oncology
Make an appointmentCall 800-789-7366

About me

  • Medical Director, Cancer Services, Penn Medicine Princeton Health
  • Clinical Associate Professor of Obstetrics and Gynecology

Education and training

  • Medical School: University of Medicine and Dentistry of New Jersey
  • Residency: Mount Sinai Medical Center
  • Fellowship: Montefiore Medical Center

What my patients think about me

Average Rating
4.9

173 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
he is also has great surgical skills.
May 2025
5.0
5.0
I appreciated Dr Goldman's kindness, humor, empathy, and candor. i felt that he was invested in my care and in how i felt during the exam and receiving information. a wonderful combination of qualities.
May 2025
5.0
5.0
my doctor answer my question, and concern my problem.
April 2025
5.0
5.0
i have been seeing dr. goldman for about two years now after my cancer surgery. he explains things and tells me what to look for.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Princeton Medical Center: Has privileges to treat patients in the hospital.
Dr. Goldman is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

My research

George, EM, Goldman NA, Burke WM Repair of a Cystotomy During a Robot-Assisted Right Ureterolysis and Upper Vaginectomy: Review of Anatomy and Surgical Techniques. , J Min Invasive Surgery, 22:S12: 2015

Burke WM, Lynch K, Goldman NA, Jones H Incidence of uterine leiomyosarcoma after laparoscopic power morcellation in a community setting. (Oral Poster) , Obstet Gynecol, 125:105S: 2015

Jones HH, Lynch K, Goldman NA, Rutledge J, Burke, William M Robotic-assisted hysterectomy complication rates are similar for all uterine weights. (Oral Poster) , Obstet Gynecol, 125:S40: 2015

Goldman NA, Lynch K, Jones, H, Rutledge J, Burke WM Comparison of complications in patients undergoing robotic-assisted hysterectomy for large leiomyomas. (Oral Poster) , Obstet Gynecol, 125: S40: 2015

Plevris, N, Burke, W, Goldman, N Non-Cutaneous Melanomas of the Genital Tract: Minimally-Invasive Robotic Treatment of Primary Vaginal Melanoma - Case Report. , J Min Invasive Surgery, 22:S241: 2015

Wright JD, Burke WM, Wilde ET, Lewin SN, Charles AS, Kim JH, Goldman N, Neugut AI, Herzog TJ, Hershman DL Comparative Effectiveness of Robotic Versus Laparoscopic Hysterectomy for Endometrial Cancer. , J Clin Oncol, 30(8):783-91: 2012

Blank SV, Christos P, Curtin JP, Goldman N, Runowicz CD, Sparano JA, Liebes L, Chen HX, Muggia FM Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment. , Gynecol Oncol, 119(3): 451-6: 2010

Goldman NA, Lee MJ, DelPriore G Cancer and Pregnancy. , Gynecology and Obstetrics: 2010

Kuo DY, Blank SV, Christos PJ, Kim M, Caputo TA, Pothuri B, Hershman D, Goldman N, Ivy PS, Runowicz CD, Muggia F, Goldberg GL, Einstein MH Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study. , Gynecol Oncol, 116(3):442-6: 2010

Wright JD, Shah M, Mathew L, Burke WM, Culhane J, Goldman N, Schiff PB, Herzog TJ Fertility preservation in young women with epithelial ovarian cancer. , Cancer, 115(18):4118-26: 2009